Stonebridge Capital Management Inc Bristol Myers Squibb CO Transaction History

Stonebridge Capital Management Inc

$224 Million
Q1 2024

A detailed history of Stonebridge Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 22,590 shares of BMY stock, worth $903,374. This represents 0.55% of its overall portfolio holdings.

Number of Shares

22,590

Previous 22,565 0.11%

Holding current value

$903,374

Previous $1.16 Million 5.79%

% of portfolio

0.55%

Previous 0.56%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $1,199 - $1,360	25 Added 0.11%	22,590 $1.23 Million
Q3 2023 Dec 13, 2023	SELL	$57.89 - $64.73 $349,655 - $390,969	-6,040 Reduced 21.12%	22,565 $1.31 Million
Q2 2023 Jul 06, 2023	SELL	$63.71 - $70.74 $44,597 - $49,518	-700 Reduced 2.39%	28,605 $1.83 Million
Q1 2023 Apr 03, 2023	SELL	$65.71 - $74.53 $16,427 - $18,632	-250 Reduced 0.85%	29,305 $2.03 Million
Q4 2022 Jan 06, 2023	SELL	$68.48 - $81.09 $140,384 - $166,234	-2,050 Reduced 6.49%	29,555 $2.13 Million

Q3 2022 Oct 06, 2022	SELL	$0.13 - $76.84 $341 - $201,705	-2,625 Reduced 7.67%	31,605 $2.25 Million
Q2 2022 Jul 01, 2022	SELL	$72.62 - $79.98 $10,893 - $11,997	-150 Reduced 0.44%	34,230 $2.64 Million
Q1 2022 Apr 04, 2022	BUY	$61.48 - $73.72 $61,480 - $73,720	1,000 Added 3.0%	34,380 $2.51 Million
Q4 2021 Jan 05, 2022	SELL	$53.63 - $62.52 $67,037 - $78,150	-1,250 Reduced 3.61%	33,380 $2.08 Million
Q3 2021 Oct 07, 2021	SELL	$59.17 - $69.31 $23,668 - $27,724	-400 Reduced 1.14%	34,630 $2.05 Million
Q2 2021 Jul 06, 2021	BUY	$61.91 - $67.42 $30,955 - $33,710	500 Added 1.45%	35,030 $2.34 Million
Q1 2021 Apr 05, 2021	SELL	$59.34 - $66.74 $86,043 - $96,772	-1,450 Reduced 4.03%	34,530 $2.18 Million
Q4 2020 Jan 06, 2021	BUY	$57.74 - $65.43 $14,435 - $16,357	250 Added 0.7%	35,980 $2.23 Million
Q3 2020 Dec 11, 2020	BUY	$57.43 - $63.64 $129,504 - $143,508	2,255 Added 6.74%	35,730 $2.16 Million
Q2 2020 Jul 07, 2020	BUY	$54.82 - $64.09 $9,319 - $10,895	170 Added 0.51%	33,475 $1.99 Million
Q1 2020 May 20, 2020	SELL	$46.4 - $67.43 $104,400 - $151,717	-2,250 Reduced 6.33%	33,305 $1.86 Million
Q4 2019 Jan 02, 2020	BUY	$49.21 - $64.19 $90,940 - $118,623	1,848 Added 5.48%	35,555 $2.28 Million
Q3 2019 Oct 02, 2019	SELL	$42.77 - $50.71 $389,335 - $461,613	-9,103 Reduced 21.26%	33,707 $1.71 Million
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $1.06 Million - $1.17 Million	23,728 Added 124.35%	42,810 $1.94 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $595,132 - $709,622	13,190 Added 223.86%	19,082 $910,000
Q2 2018 Jul 06, 2018	SELL	$50.53 - $62.98 $151,590 - $188,940	-3,000 Reduced 33.74%	5,892 $330,000
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $532,986 - $581,092	8,892	8,892 $558,000

Others Institutions Holding BMY

# of Institutions

2,555

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Account

Stonebridge Capital Management Inc Bristol Myers Squibb CO Transaction History